Mullen Automotive Inc. (NASDAQ: MULN) is an emerging electric vehicle (EV) manufacturer based in Southern California. With a focus on the commercial EV space, Mullen Automotive is making great strides in the production and delivery of its Class 1 and Class 3 commercial EVs. The company's subsidiary, Mullen Advanced Energy LLC, is also moving forward with the installation of its battery-pack production line at its new facility in Fullerton, California. Mullen Automotive is committed to increasing its production capacity to meet the growing demand for its American-made EVs and aims to reduce battery costs and improve its gross profit margin per vehicle produced. Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company that is dedicated to developing life-changing therapies for patients with cancer and diabetes. The company has recently enrolled and dosed the first patient in the phase 2a expansion portion of its Acclaim-1 clinical study. This study focuses on Reqorsa R therapy, also known as quaratusugene ozeplasmid, and aims to provide innovative treatment options for patients. Genprex is committed to advancing its gene therapy platform to address unmet medical needs and improve the lives of patients.
Generated from the website